124 related articles for article (PubMed ID: 10205781)
1. Cyclin D1 overexpression and p53 mutation status in epithelial ovarian cancer.
Shigemasa K; Tanimoto H; Parham GP; Parmley TH; Ohama K; O'Brien TJ
J Soc Gynecol Investig; 1999; 6(2):102-8. PubMed ID: 10205781
[TBL] [Abstract][Full Text] [Related]
2. Cyclin E mRNA overexpression in epithelial ovarian cancers: inverse correlation with p53 protein accumulation.
Sawasaki T; Shigemasa K; Shiroyama Y; Kusuda T; Fujii T; Parmley TH; O'Brien TJ; Ohama K
J Soc Gynecol Investig; 2001; 8(3):179-85. PubMed ID: 11390254
[TBL] [Abstract][Full Text] [Related]
3. p16 overexpression: a potential early indicator of transformation in ovarian carcinoma.
Shigemasa K; Hu C; West CM; Clarke J; Parham GP; Parmley TH; Korourian S; Baker VV; O'Brien TJ
J Soc Gynecol Investig; 1997; 4(2):95-102. PubMed ID: 9101469
[TBL] [Abstract][Full Text] [Related]
4. Association of downregulation of cyclin D1 and of overexpression of cyclin E with p53 mutation, high tumor grade and poor prognosis in hepatocellular carcinoma.
Peng SY; Chou SP; Hsu HC
J Hepatol; 1998 Aug; 29(2):281-9. PubMed ID: 9722210
[TBL] [Abstract][Full Text] [Related]
5. [Clinicopathologic analysis and expression of cyclin D1 and p53 of ovarian borderline tumors and carcinomas].
Shao HL; Shen DH; Xue WC; Li Y; Yu YZ
Zhonghua Fu Chan Ke Za Zhi; 2007 Apr; 42(4):227-32. PubMed ID: 17631760
[TBL] [Abstract][Full Text] [Related]
6. Cyclin D1 overexpression in rat two-stage bladder carcinogenesis and its relationship with oncogenes, tumor suppressor genes, and cell proliferation.
Lee CC; Yamamoto S; Wanibuchi H; Wada S; Sugimura K; Kishimoto T; Fukushima S
Cancer Res; 1997 Nov; 57(21):4765-76. PubMed ID: 9354438
[TBL] [Abstract][Full Text] [Related]
7. Mutation and overexpression of p53 in early-stage epithelial ovarian cancer.
Kohler MF; Kerns BJ; Humphrey PA; Marks JR; Bast RC; Berchuck A
Obstet Gynecol; 1993 May; 81(5 ( Pt 1)):643-50. PubMed ID: 8469448
[TBL] [Abstract][Full Text] [Related]
8. Frequent loss of PTEN expression is linked to elevated phosphorylated Akt levels, but not associated with p27 and cyclin D1 expression, in primary epithelial ovarian carcinomas.
Kurose K; Zhou XP; Araki T; Cannistra SA; Maher ER; Eng C
Am J Pathol; 2001 Jun; 158(6):2097-106. PubMed ID: 11395387
[TBL] [Abstract][Full Text] [Related]
9. Molecular pathology of primary and metastatic ductal pancreatic lesions: analyses of mutations and expression of the p53, mdm-2, and p21/WAF-1 genes in sporadic and familial lesions.
Ruggeri BA; Huang L; Berger D; Chang H; Klein-Szanto AJ; Goodrow T; Wood M; Obara T; Heath CW; Lynch H
Cancer; 1997 Feb; 79(4):700-16. PubMed ID: 9024708
[TBL] [Abstract][Full Text] [Related]
10. Loss of expression of the p16 tumor suppressor gene is more frequent in advanced ovarian cancers lacking p53 mutations.
Havrilesky LJ; Alvarez AA; Whitaker RS; Marks JR; Berchuck A
Gynecol Oncol; 2001 Dec; 83(3):491-500. PubMed ID: 11733961
[TBL] [Abstract][Full Text] [Related]
11. Cyclin gene amplification and overexpression in breast and ovarian cancers: evidence for the selection of cyclin D1 in breast and cyclin E in ovarian tumors.
Courjal F; Louason G; Speiser P; Katsaros D; Zeillinger R; Theillet C
Int J Cancer; 1996 Aug; 69(4):247-53. PubMed ID: 8797862
[TBL] [Abstract][Full Text] [Related]
12. Analysis of p53, p16(INK4a), pRb and Cyclin D1 expression and human papillomavirus in primary ovarian serous carcinomas.
Bilyk OO; Pande NT; Buchynska LG
Exp Oncol; 2011 Sep; 33(3):150-6. PubMed ID: 21956468
[TBL] [Abstract][Full Text] [Related]
13. Nuclear cyclin D1 overexpression is a critical event associated with cell proliferation and invasive growth in gallbladder carcinogenesis.
Itoi T; Shinohara Y; Takeda K; Nakamura K; Takei K; Sanada J; Horibe T; Saito T; Kasuya K; Ebihara Y
J Gastroenterol; 2000; 35(2):142-9. PubMed ID: 10680670
[TBL] [Abstract][Full Text] [Related]
14. Sohlh2 inhibits ovarian cancer cell proliferation by upregulation of p21 and downregulation of cyclin D1.
Zhang H; Zhang X; Ji S; Hao C; Mu Y; Sun J; Hao J
Carcinogenesis; 2014 Aug; 35(8):1863-71. PubMed ID: 24858206
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of cyclin D1 and c-Myc gene products in human primary epithelial ovarian cancer.
Chen CH; Shen J; Lee WJ; Chow SN
Int J Gynecol Cancer; 2005; 15(5):878-83. PubMed ID: 16174239
[TBL] [Abstract][Full Text] [Related]
16. p53 mutation is infrequent in clear cell carcinoma of the ovary.
Ho ES; Lai CR; Hsieh YT; Chen JT; Lin AJ; Hung MH; Liu FS
Gynecol Oncol; 2001 Feb; 80(2):189-93. PubMed ID: 11161858
[TBL] [Abstract][Full Text] [Related]
17. p53 and Ki-ras gene mutations in epithelial ovarian neoplasms.
Teneriello MG; Ebina M; Linnoila RI; Henry M; Nash JD; Park RC; Birrer MJ
Cancer Res; 1993 Jul; 53(13):3103-8. PubMed ID: 8319218
[TBL] [Abstract][Full Text] [Related]
18. miR-211 suppresses epithelial ovarian cancer proliferation and cell-cycle progression by targeting Cyclin D1 and CDK6.
Xia B; Yang S; Liu T; Lou G
Mol Cancer; 2015 Mar; 14():57. PubMed ID: 25889927
[TBL] [Abstract][Full Text] [Related]
19. Analysis of p53 mutation and cyclin D1 expression in breast tumors.
Tanyi J; Tory K; Bánkfalvi A; Shröder W; Rath W; Füzesi L
Pathol Oncol Res; 1999; 5(2):90-4. PubMed ID: 10393358
[TBL] [Abstract][Full Text] [Related]
20. Cyclin D1 and p21 in ulcerative colitis-related inflammation and epithelial neoplasia: a study of aberrant expression and underlying mechanisms.
Wong NA; Mayer NJ; Anderson CE; McKenzie HC; Morris RG; Diebold J; Mayr D; Brock IW; Royds JA; Gilmour HM; Harrison DJ
Hum Pathol; 2003 Jun; 34(6):580-8. PubMed ID: 12827612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
